ABSTRACT: Background. The purpose of this study was to present our evaluation of the clinical and functional outcomes after salvage total laryngectomy (STL). Methods. We conducted a retrospective review of 218 patients who underwent STL between 1994 and 2014. Results. Seventy percent of patients originally had T1 or T2, N0 tumors and 73% had definitive external-beam radiotherapy (EBRT) alone. A majority utilized tracheoesophageal prosthesis (77%) and were gastrostomy free (80%) at last follow-up. The 5-year disease control and overall survival (OS) rates were 65% and 57%, respectively. Patients with a disease-free interval after initial treatment <2 years were more likely to develop a recurrence (p 5 .001) and die of disease (p 5 .032) after STL. The disease-free interval after EBRT impacted disease control (p < .001), with 5-year disease control of 92% for >5-year disease-free interval and 60% for <2-year disease-free interval. Conclusion. Most patients remain disease-free after STL, achieve intelligible tracheoesophageal speech, and maintain an oral diet. Delayed recurrence after initial treatment portends better survival and may indicate a distinct biological profile.
INTRODUCTION
Laryngeal squamous cell carcinoma (SCC) is diagnosed in approximately 20,000 patients annually in the United States. 1 The 1991 Veterans Affairs cooperative study created a shift from primary surgery to nonsurgical treatment regimens for advanced laryngeal cancer. 2 Numerous retrospective studies from various institutions have demonstrated excellent clinical outcomes for early-stage laryngeal cancer treated with definitive external-beam radiotherapy (EBRT). [3] [4] [5] The combination of these datasets has resulted in a widespread shift away from surgery toward radiotherapy for most primary laryngeal tumors. As a result, surgery for laryngeal cancer is now most often performed in the setting of recurrent disease or incomplete tumor response to nonsurgical treatment. Despite extensive research over the last 30 years, several studies have suggested that survival for patients with laryngeal cancer may be declining 6, 7 ; and some have suggested the decline could be related to treatment of T4 laryngeal SCCs with organ preservation protocols. 8, 9 Salvage total laryngectomy (STL) remains the standard treatment for advanced recurrent/residual local laryngeal disease after EBRT. [10] [11] [12] Previous studies have reported approximately 50% to 70% of patients alive and diseasefree 5 years after STL. [13] [14] [15] [16] Initial and recurrent tumor classification have varyingly correlated with outcomes for patients undergoing STL. 13 Our group has previously published data indicating that lack of a disease-free interval after definitive EBRT for oropharyngeal cancer is associated with poor clinical outcomes. 17 We hypothesized that lack of a disease-free interval after initial treatment would also be associated with poor clinical outcomes in laryngeal cancer. To test this hypothesis and other factors that may influence outcomes after STL, we retrospectively reviewed all patients undergoing STL at The University of Texas MD Anderson Cancer Center between the years 1994 and 2014.
MATERIALS AND METHODS

Patients
After approval by the University of Texas MD Anderson Cancer Center institutional review board, we reviewed the medical records of 259 patients with recurrent laryngeal SCC who underwent STL between 1994 and 2014. Patients with hypopharyngeal tumors (6 patients) at the time of initial presentation were excluded from the study, as were patients who underwent surgical treatment before, or in addition to EBRT 1/-chemotherapy (35 patients), such that the final study population was 218 patients. Demographics, tobacco and alcohol exposure, and patient clinical-pathologic history were comprehensively reviewed through the institutional electronic medical records. Tumor classification was conducted according to the American Joint Commission on Cancer staging system. Because many patients had their initial cancer treatment at outside institutions, precise T and N classifications were unavailable for 69 patients, whereas precise tumor site (larynx vs hypopharynx) could not be determined for 2 patients. Patients were considered to have a smoking history if they were current smokers or former smokers with >10 pack/year history. All patients had biopsy proven recurrence before STL. Speech and swallowing data were censored at the time of last followup or disease-related functional deterioration. The disease-free interval was defined as the time period between completion of treatment for the initial tumor and the time of recurrence before STL.
Study endpoints and statistical analysis
Endpoints included time to second recurrence after STL and death. Time to second recurrence was calculated as the date of STL to the date of recurrence after STL. Overall survival (OS) after STL was calculated as the date of STL to the date of death. Actuarial survival rates were generated using the Kaplan-Meier method, and comparisons between groups were made using log-rank statistics. Univariate analysis was performed using Cox regression. All variables with p .1 on univariate analysis were used for multivariate analysis. Statistical calculations were performed with SPSS version 16.0. For all statistics, p values were considered to be statistically significant if below a threshold of .05 (2-sided).
RESULTS
Patient and tumor characteristics
Patient demographics and smoking history are summarized in Table 1 . Tumor characteristics are summarized in Table 2 . Fifty-two patients (24%) reported continued smoking between their initial diagnosis of laryngeal cancer and STL. Mean and median age were 64 years (SD 5 10 years) and 64 (range, 40-88 years), respectively. At initial presentation before primary treatment, most patients were men (87%), current or former smokers (94%), with primary tumors of the glottic larynx (68%), early T classification (70%), and no neck disease (89%).
Primary treatment characteristics
One hundred sixty patients were treated with curative intent EBRT and 58 were treated with curative intent chemo-EBRT Table 3 . Patients who were treated surgically before STL were excluded from the study.
Salvage treatment characteristics
All patients underwent STL Table 3 . Patients were classified into 1 of 2 groups: STL for early recurrence (<2 years from end of previous treatment; n 5 150) or STL for late recurrence (>2 years from end of previous treatment; n 5 68). Mean and median disease-free interval before STL was 806 days and 369 days, respectively. Mean and median time from diagnosis of recurrent disease to STL was 42 and 42 days, respectively. One hundred ten patients (50%) underwent a lateral neck dissection (unilateral or bilateral) and 106 patients (49%) underwent primary tracheoesophageal prosthesis (TEP) placement. We evaluated the potential impact of elective neck dissection using pathologic data. Of 23 patients noted to have pathologically positive lymph nodes after STL, 17 patients (74%) had clinical or imaging evidence of nodal disease on preoperative workup, whereas 6 patients (26%) had occult nodal disease. The rate of occult nodal disease in those without preoperative evidence of disease was 5% (6 of 110 patients). Reinforcement of the pharyngeal closure using a local flap (sternocleidomastoid muscle or pectoralis major myofascial/myocutaneous) was performed in 19 patients (9%), and free flap reconstruction was utilized in 42 patients (19%). Treatment patterns changed over time with respect to primary TEP placement and free flap utilization. 
Complications
Twenty-nine patients (13%) required return to the operating room for post-STL complications. Of these patients, 18 had fistula, 8 had hematoma, and 1 had revision of free flap anastomosis; 8 patients required multiple surgeries for complications. There was 1 perioperative death, a 93-year-old female patient who died of unknown causes in a skilled nursing facility 8 days after STL. Of the 18 patients who developed fistulas requiring reoperation, 4 of 42 had undergone free flap reconstruction (fistula rate of 10%), 2 of 19 had undergone pedicled flap reconstruction (fistula rate of 11%), and 14 of 157 had undergone primary closure (fistula rate of 9%). Patients who had presalvage laryngectomy chemo-EBRT had higher rates of fistula formation (9 of 58; 16%) than patients treated with EBRT alone (9 of 160; 6%; z-test, p < .05). The higher rate of fistula formation for chemo-EBRT occurred despite the use of 29 free flap reconstructions utilized at the time of STL for this patient group (23 of 58 patients; 40%), compared to 19 free flap reconstructions utilized at the time of STL in the context of previous EBRT alone (19 of 160 patients; 12%). Eleven fistulas occurred in patients who underwent a lateral neck dissection along with STL (11 of 110; 10%) compared with 7 fistulas that occurred in patients who did not undergo a lateral neck dissection along with STL (7 of 108; 6%); this difference was not statistically significant.
Functional outcomes after salvage total laryngectomy
A total of 156 patients underwent TEP placement, of which 106 were primary TEPs at the time of STL, and 50 were secondary TEPs performed in a delayed fashion after STL. One patient underwent primary TEP placement with spontaneous closure, followed by secondary TEP placement. At last follow-up (and before any diseaserelated functional decline), 120 patients utilized TEP, 1 utilized esophageal speech, 74 utilized electrolarynx, and 19 utilized writing as a means of communication. Data were not readily available for 3 patients. Among patients who underwent TEP placement, 120 of 156 (77%) utilized TEP as the primary means of communication at last follow-up. Forty-five patients (20%) continued to utilize a gastrostomy tube, whereas 166 were gastrostomy-free (data not available on 7 patients). Gastrostomy tube utilization at the time of last disease-free follow-up was more common among patients who underwent free flap reconstruction at the time of STL (19 of 42; 45%) compared with those patients who did not undergo free flap reconstruction at the time of STL (26 of 176; 15%; p < .05).
Recurrent disease characteristics
Among pathology reports that included PNI or lymphovascular invasion (LVI), 32% of specimens were positive for PNI and 14% were positive for LVI. Positive margins were noted in 7% of specimens. Of the 23 specimens that demonstrated positive lymph nodes (11%), extracapsular extension was noted in 14 (61%).
Recurrence and survival postsalvage total laryngectomy
The overall mean and median follow-up time post-STL for all 218 patients were 4.7 and 3.4 years, respectively. Seventy-two percent and 65% of the patients were recurrence-free at 2 and 5 years post-STL, respectively, whereas OS at 2 and 5 years were 75% and 57%, respectively (see Figure 1) . Sixty-four patients (29%) demonstrated recurrence after STL, with mean and median time to recurrence of 344 and 247 days, respectively (range, 0-1737 days). Patterns of recurrence were as follows: 9 local only, 21 regional only, 21 distant only, 5 local and regional, 1 local and distant, and 7 regional and distant. Among the 33 patients who experienced regional recurrence, 15 recurred along the internal jugular chain, 8 recurred in the paratracheal/paraesophageal chain, 4 had soft tissue peristomal recurrences, and 6 patients recurred at multiple sites throughout the neck; only 5 patients recurred along the internal jugular chain after having undergone a lateral neck dissection on that side at the time of STL. Of the 23 patients who exhibited pathologically positive lymph nodes at the time of STL, 14 had extracapsular extension, whereas 9 did not have extracapsular extension. Among the 14 patients with extracapsular extension, 5 (36%) developed regional recurrence, whereas 2 of 9 patients (22%) without extracapsular extension developed regional recurrence (p 5 NS).
Performing a lateral neck dissection had no statistically significant impact on regional recurrence; 17 of 110 patients (15%) who underwent lateral neck dissection developed regional recurrence compared to 16 of 118 patients (14%) who did not undergo lateral neck dissection. Of the 23 patients with pathologically positive lymph nodes, 17 demonstrated pre-STL clinical or imaging evidence of nodal disease. After removing these 17 patients, we evaluated the impact of neck dissection on regional recurrence. In this subset of 201 patients without preoperative evidence of neck disease, 13 patients developed regional recurrence after STL and neck dissection (13 of 95; 14%) compared with 15 patients who developed regional recurrence after STL without neck dissection (15 of 106; 14%; p 5 NS).
Five patients developed a new primary in the upper aerodigestive tract, and all 5 of these patients received definitive treatment for their second primary malignancy. Among patients who recurred, 12 were alive at last contact and 52 were dead (mortality rate 83%). Among all patients at last follow-up, 109 were alive and 109 were dead (mortality rate 50%). Of the patients who died, 47 died of recurrent/metastatic disease, whereas 22 died of other malignancies.
The impact of patient, tumor, and initial treatment characteristics on recurrence and survival after total laryngectomy was ascertained via univariate analysis. PNI or LVI did not significantly impact time to recurrence or OS. Only nodal status at the time of STL and the time between completion of initial treatment and STL (ie, disease-free interval) correlated with OS and time to recurrence on univariate analysis. These variables were confirmed to correlate with both time to recurrence and OS on multivariate analysis (Table 4) .
A total of 26 patients (12%) exhibited a disease-free interval >5 years after initial EBRT. Among these patients, only 2 patients experienced recurrence after STL; both patients died of their disease. Among all 26 patients, 11 were dead at last follow-up. Forty-two patients (19%) exhibited a disease-free interval after initial EBRT of 2 to 5 years. Among these patients, 7 experienced recurrence after STL; and 17 patients were dead at last follow-up. Among 150 patients with a disease-free interval <2 years, 55 patients experienced recurrence; and 81 were dead at last follow-up. The overall recurrence rates for the 3 groups post-STL (<2 years, 2-5 years, >5 years disease-free interval before STL) were 36%, 17%, and 8%, respectively. This is a linear relationship with an R 2 value of 0.97. Kaplan-Meier analysis of these 3 patient subgroups demonstrated a statistically significant impact of the disease-free interval after EBRT on clinical outcomes after STL (see Figure 2) . Pairwise comparison demonstrated a statistically significant difference in OS between patients with a disease-free interval of 2 to 5 years compared with patients with a disease-free interval <2 years (p 5 .037).
DISCUSSION
In this large series of 218 patients with recurrent SCC of the larynx after previous EBRT, STL provides acceptable disease control of 2 (72%) and 5 (65%) years postsurgery. Disease control after STL further improves with the length of the disease-free interval after the initial EBRT completion, such that >90% of patients with a diseasefree interval >5 years demonstrate long-term disease control. In contrast, OS after STL at 5 years drops to 57%, consistent with other studies of salvage total laryngectomy. [13] [14] [15] [16] The dichotomy between disease control and OS is not unexpected in a cohort of patients with older age, significant smoking history, multiple comorbidities, and second primary malignancies. Approximately 20% of patients who died in this cohort without recurrent disease succumbed to second primary malignancies, a statistic that likely significantly underrepresents the effect of second primary malignancy, given that many patients died of unknown causes.
A disease-free interval after the end of EBRT for primary disease was a major factor influencing both disease recurrence and OS. Among patients with a disease-free interval >5 years, only 8% developed recurrence after STL and the 2-year OS was approximately 80%. It is quite possible that many of these patients with a diseasefree interval >5 years represent those with second primary laryngeal tumors in contrast to true recurrences, which likely partially accounts for the improved survival in this subset of patients. The delayed recurrence would potentially portend less aggressive tumor biology, whether it was a true recurrence of the same tumor clone or a second primary tumor with more favorable tumor biology. Previous studies have similarly shown a disease-free interval to be an important prognostic factor in other head and neck upper aerodigestive tract sites. 17 The presence of neck disease generally decreases survival in laryngeal SCC by nearly 50%. 18, 19 The current data confirm the finding that patients with recurrent neck disease at the time of STL are nearly 4 times more likely to develop recurrent disease and >3 times more likely to die after STL. Almost half of the patients with disease recurrence in this cohort had regional disease recurrence, whereas <20% had local disease recurrence. Extracapsular extension was not significantly correlated with an increased rate of regional recurrence, although the numbers available for this analysis were very small. The role of elective neck dissection during STL remains unclear. Although some authors have illustrated improved survival outcomes with elective neck dissection, [20] [21] [22] others have demonstrated no benefit. 23, 24 In our cohort, the rate of occult nodal disease among patients who underwent neck dissection in the absence of preoperative clinically evident nodal burden was 5%. Among patients with no pre-STL clinical or radiographic neck disease, neck dissection with STL did not significantly impact the risk of regional recurrence when compared with patients who did not undergo neck dissection. However, even factoring out patients with pre-STL neck disease, there remains an obvious selection bias between those patients who underwent neck dissection at the time of STL versus those who did not. Although we did not identify a clear benefit to elective lateral neck dissection in this study, it is difficult to account for this inherent selection bias in order to meaningfully determine whether the patients who developed regional recurrence in the absence of neck dissection with STL could have potentially benefited from an elective neck dissection.
The overall rate of regional recurrence in this cohort was 15%, in keeping with previously published studies of salvage laryngectomy. Five patients (<5% of patients who had a lateral neck dissection) developed a recurrence in a previously dissected lateral neck, whereas 12 patients (6%) had paratracheal or peristomal soft tissue recurrences. Potential reasons for these recurrences include a missed regional node at the time of initial lateral neck or central compartment dissection; perineural spread; or soft tissue recurrence because of extranodal extension at the time of surgery, because very few of these patients were able to undergo further radiation for any potential microscopic disease after STL. Additionally, there can be difficulty in distinguishing local versus regional recurrence with respect to central compartment/peristomal recurrences, and because these patients were considered to have regional recurrence, it is possible that this number may be slightly artificially high in terms of true regional recurrence. Finally, several of the central compartment recurrences occurred in the superior mediastinal lymph nodes just inferior to the field of previous dissection. Overall, these data are comparable with previous series that have reported local recurrence rates as high as 26% and locoregional control rates in the 74% to 90% range, although some smaller series have reported no isolated regional recurrences after STL. 16, 18, 24 Although adjuvant reirradiation with or without chemotherapy is a potential option after STL, relatively few patients undergo reirradiation in practice (only 6% reirradiation in the current cohort) because of morbidity/toxicity and equivocal impact on survival. 25 For those who can undergo reirradiation, the impact seems to be primarily limited to disease-free survival and to those with highrisk pathologic features (PNI, LVI, positive margins). 26 In the current cohort, too few patients underwent adjuvant treatment to determine any potential impact on clinical outcomes.
Postoperative complications requiring reoperation occurred in 13% of patients in this cohort, most commonly for fistula, with an 8% rate of fistula formation requiring reoperation. Neck dissection with STL did not negatively impact the rate of fistula formation after STL. There was no difference in fistula rates in this cohort between patients closed primarily, those closed with the addition of a pectoralis muscle flap, and those closed with a free tissue transfer. However, the fistula rates do not take into account an inherent selection bias, in that patients with more advanced disease and more significant pharyngeal resections were presumably more likely to be closed with the addition of a pectoralis flap or free tissue transfer. One example of this inherent selection bias is illustrated by the finding that patients who were initially treated with chemo-EBRT were more likely to undergo free flap reconstruction compared to those initially treated with EBRT alone. Others have previously reported lower fistula rates with vascularized free tissue transfer or pedicled pectoralis flap when compared to primary closure. [27] [28] [29] [30] [31] At this institution, free flap reconstruction has become increasingly utilized in pharyngeal reconstruction after STL, with 42% of STLs since 2007 reconstructed with vascularized free tissue transfer, most commonly from the radial forearm or anterior lateral thigh. The primary indication for free flap reconstruction with STL at this institution is the extent of pharyngeal resection (partial or total pharyngectomy), with concurrent chemotherapy in the treatment of the primary disease as a secondary factor. In the current study, postoperative adjuvant chemotherapy was significantly correlated with higher rates of fistula formation requiring reoperation, despite a higher rate of free flaps in this population of patients. The addition of vascularized tissue should be considered for this patient population who undergo STL after chemoradiotherapy, as is the current practice of most head and neck surgeons at this institution.
Restoration of speech and swallowing functions are essential to providing meaningful quality of life post-STL. 32 The current study demonstrates that a greater utilization of free flap reconstruction at the time of STL has been accompanied by a decrease in the rate of primary TEP placement and a concomitant decrease in the total number of TEP procedures among patients who undergo STL. Speech language pathologists at this institution generally prefer secondary TEPs in this patient population who undergo free flap pharyngeal reconstruction, as it potentially allows better assessment of tracheoesophageal speech potential and fewer ultimate failed TEP users, as well as potentially more accurate TEP placement and improved voice results after postoperative wound healing.
As organ preservation protocols have become more prevalent in the treatment of laryngeal SCC, tertiary referral centers may be receiving a greater proportion of patients with advanced recurrent laryngeal disease after EBRT. At the same time, the increasing reliability of free flap reconstruction over the last several decades has allowed surgeons to operate on patients who require greater amounts of pharyngeal mucosal resection. 33, 34 However, even with advancements in free flap reconstruction, inherent dynamic pharyngeal functionality often may not be maintained. Therefore, it is not surprising that the rate of chronic percutaneous endoscopic gastrostomy tube utilization among STL patients requiring free flap reconstruction was found to be 45%, over 3 times higher than that of patients who did not require free flap reconstruction. Although the majority of patients who had feeding tubes were able to tolerate some degree of an oral diet, the relatively high rate of at least partial feeding tube dependence related to pharyngeal dynamic dysfunction in this patient population should not be underestimated. In the elderly population, pretreatment dysphagia, along with surgery and adjuvant EBRT, are all associated with longterm dysphagia. 35 Smaller series evaluating dysphagia in similar populations have reported gastrostomy tube rates in the 13% to 16%, although many of the larger series simply do not describe swallowing outcomes in detail. 36, 37 Similarly, this loss of pharyngeal functionality contributes to lower rates of TEP procedures and tracheoesophageal speech utilization among STL patients requiring free flap reconstruction.
CONCLUSION
Approximately two thirds of patients undergoing STL for recurrent SCC of the larynx remain disease-free, and over half remain alive at 5 years post-STL. Most patients undergo TEP and achieve intelligible tracheoesophageal speech, whereas 20% of patients remain gastrostomy tube-dependent. Factors that significantly impact recurrence and OS include disease-free interval after initial EBRT and recurrent nodal status. Patients with greater disease-free interval demonstrate progressively better disease control and OS, a factor that likely portends to progressively more favorable tumor biology.
